Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience

被引：4

作者：

Lachenal, Florence ^{[1
]}

Lebreton, Pierre ^{[2
]}

Bouillie, Sylvie ^{[3
]}

Matteo, Gian ^{[4
]}

Aftisse, Hassina ^{[5
]}

Pascal, Laurent ^{[6
]}

Montes, Lydia ^{[7
]}

Macro, Margaret ^{[8
]}

Vignon, Marguerite ^{[9
]}

Harel, Stephanie ^{[10
]}

Fernandez, Mariana ^{[11
]}

Louni, Chanaz ^{[12
]}

Huart, Antoine ^{[13
]}

Perrot, Aurore ^{[14
]}

机构：

[1] GHND Grp Hosp Nord Dauphine, Bourgoin Jallieu, France

[2] Grp Hosp Havre, Le Havre, France

[3] Janssen, Issy Les Moulineaux, France

[4] CH Chambery, Dept Hematol, Chambery, France

[5] Ctr Hosp St Quentin, St Quentin en Yvelines, France

[6] Hop St Vincent De Paul, Lille, France

[7] Ctr Hosp Univ Amiens Picardie, Serv Hematol, Amiens, France

[8] Hop Cote Nacre, Caen, France

[9] Hop Cochin, AP HP, Hematol Clin, Paris, France

[10] St Louis Hosp, Paris, France

[11] Janssen Cilag Spain, Madrid, Spain

[12] IFM, Paris, France

[13] CHU Toulouse Rangueil, Dept Nephrol & Transplantat, Toulouse, France

[14] Univ Toulouse, CHU Toulouse, IUCT O, UPS,Serv Hematol, Toulouse, France

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180660

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Peripheral Neuropathy Experience in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Carfilzomib
Martin, Thomas G.
ONCOLOGY-NEW YORK, 2013, 27 : 4 - 10
[32] REAL-LIFE EXPERIENCE WITH POMALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Cubillas, Garcia de la Torre Damian
Inigo, Rodriguez Belen
Alfayate, Lobo Ana
Menendez, Cuevas Marina
Bolanos, Calderon Estefania
Medina, Salazar Sissy Fiorella
Mateo, Morales Marta
Pena, Cortijo Ascension
Perez, Lopez Cristina
Polo, Zarzuela Marta
Calo, Perez Aida
Colas, Lahuerta Blanca
Gomez, Alvarez Miguel
Escribano, Serrat Silvia
Estival, Monteliu Pablo
Gulino, Horacio
Daorta, Melisa
Moreno, Paredes Nahir Daniela
Benavente, Cuesta Celina
HAEMATOLOGICA, 2020, 105 : 151 - 151
[33] Autologous retransplantation in patients with relapsed or refractory multiple myeloma - experience of two centers
Karp, S.
Teipel, R.
Zolnowski, D.
Trautmann-Grill, K.
Pannach, M.
Zinn, J.
Roellig, C.
Haenel, A.
Herbst, R.
Kroschinsky, F.
Morgner, A.
von Bonin, M.
Bornhaeuser, M.
Haenel, M.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 236 - 236
[34] Bortezomib in relapsed and refractory multiple myeloma patients.: Experience of a single center
Calabrese, E.
Gallucci, C.
Federico, V
Mohamad, A.
Foa, R.
Petrucci, M. T.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
[35] Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies
Firestone, Ross
Shekarkhand, Tala
Patel, Dhwani
Tan, Carlyn Rose Co
Hultcrantz, Malin
Lesokhin, Alexander M.
Mailankody, Sham
Hassoun, Hani
Shah, Urvi A.
Korde, Neha
Maclachlan, Kylee
Landau, Heather Jolie
Scordo, Michael
Chung, David J.
Shah, Gunjan L.
Lahoud, Oscar Boutros
Giralt, Sergio
Usmani, Saad Zafar
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[36] Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
Xin Miao
Liviawati S. Wu
Shun Xin Wang Lin
Yan Xu
Yang Chen
Yuki Iwaki
Rachel Kobos
Tara Stephenson
Kristy Kemmerer
Clarissa M. Uhlar
Arnob Banerjee
Jenna D. Goldberg
Danielle Trancucci
Amit Apte
Raluca Verona
Lixia Pei
Rachit Desai
Kathleen Hickey
Yaming Su
Daniele Ouellet
Mahesh N. Samtani
Yue Guo
Alfred L. Garfall
Amrita Krishnan
Saad Z. Usmani
Honghui Zhou
Suzette Girgis
Targeted Oncology, 2023, 18 : 667 - 684
[37] Characterization of Anthropometric Changes in Patients with Relapsed/Refractory Myeloma Treated with BCMA Bispecific Antibody Teclistamab
Nader, Setarah Mohammad
Jines, Tyler
Collier, Christopher
Zimmers, Teresa
Abonour, Rafat
Farag, Sherif
Abu Zaid, Mohammad
Lee, Kelvin P.
Suvannasankha, Attaya
BLOOD, 2023, 142
[38] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
Stepanovic, Adam
Abonour, Rafat
Abu Zaid, Mohammad
Farag, Sherif
Lee, Kelvin P.
Suvannasankha, Attaya
BLOOD, 2023, 142
[39] Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
Miao, Xin
Wu, Liviawati S.
Lin, Shun Xin Wang
Xu, Yan
Chen, Yang
Iwaki, Yuki
Kobos, Rachel
Stephenson, Tara
Kemmerer, Kristy
Uhlar, Clarissa M.
Banerjee, Arnob
Goldberg, Jenna D.
Trancucci, Danielle
Apte, Amit
Verona, Raluca
Pei, Lixia
Desai, Rachit
Hickey, Kathleen
Su, Yaming
Ouellet, Daniele
Samtani, Mahesh N.
Guo, Yue
Garfall, Alfred L.
Krishnan, Amrita
Usmani, Saad Z.
Zhou, Honghui
Girgis, Suzette
TARGETED ONCOLOGY, 2023, 18 (05) : 667 - 684
[40] POMALIDOMIDE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): EXPERIENCE CENTER
Cuesta Garcia, A.
HAEMATOLOGICA, 2015, 100 : 104 - 104

← 1 2 3 4 5 →